Taiyuan Maichuang Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Taiyuan Maichuang Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include VUKJLOP. The owner is based in Taiyuan, Shanxi.

Room 0317, 3rd Floor, South Tower, Building 1, No. 28

South Inner Ring West Street, Changfeng West Street, Wanbailin District

Taiyuan, Shanxi 030024 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VUKJLOP
VUKJLOP
Registered 2025

Trademark Classifications

Taiyuan Maichuang Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Taiyuan Maichuang Trading Co., Ltd. have?

Taiyuan Maichuang Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Taiyuan Maichuang Trading Co., Ltd. file in?

Taiyuan Maichuang Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Taiyuan Maichuang Trading Co., Ltd.'s most well-known trademarks?

Taiyuan Maichuang Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as VUKJLOP. These are among 1 currently registered trademark in the portfolio.

What is Taiyuan Maichuang Trading Co., Ltd.'s trademark registration success rate?

Taiyuan Maichuang Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.